创新价值的驱动因素:基于系统动态建模的新药定价评估模拟
Qian Xing1, Wendi Cheng1, Wei Wang1
1Department of Health Technology Assessment, Shanghai Health Development Research Center (Shanghai Medical Information Center), Shanghai, China.
由于政策的变化,日本的药品价格正在上,特别是对于罕见疾病的治疗方法. 诸如疗效和新疗法等因素显著影响药物价值和市场成功.
科学领域:
- 制药经济学 制药经济学
- 卫生技术评估 卫生技术评估
- 药品定价政策 药品定价政策
背景情况:
- 支付创新药价值对于医疗保健效率和患者的结果至关重要.
- 了解影响创新溢价的因素是导航制药生态系统的关键.
研究的目的:
- 通过使用系统动态,构建日本新药定价决策评估系统.
- 整合各种决策因素,包括价值,可销售性,儿科和SAKIGAKE保险费.
主要方法:
- 使用了系统动态建模.
- 使用Vensim PLE软件进行模拟.
- 多种决策因素被整合到评估系统中.
主要成果:
- 在目前的政策下,制药创新显示出增长,五年后有显著的影响.
- 罕见病和利基市场药物的价值增长最为显著.
- 组合疗法,更快的作用机制和新的治疗成分强烈影响药物价值.
结论:
- 临床结果是药品定价的核心,影响市场动态和患者/提供者偏好.
- 监管框架必须优先考虑未满足的需求和卓越的有效性.
- 未来的模型应该整合现实世界的证据和扩展的监管考虑,以公平,基于结果的定价.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
07:41Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
Published on: June 5, 2017
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Model Approaches for Pharmacokinetic Data: Physiological Models
